塔克索尔开发中的战略:一篇评论
Justyna Zwawiak1, Lucjusz Zaprutko1, Anna Pawelczyk1
1Department of Organic Chemistry, Pharmaceutical Faculty, Poznan University of Medical Sciences, Rokietnicka 3, 60- 806, Poznan, Poland.
Mini reviews in medicinal chemistry
|October 3, 2024
概括
研究人员正在探索新的方法来获得强效抗癌化合物Taxol. 生物技术方法,纳米技术和人工智能正在提高Taxol的生产和输送,以改善癌症治疗.
科学领域:
- 自然产品化学 自然产品化学
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 塔克索 (帕克利塔塞尔) 是一种具有显著抗瘤特性的二烯化合物.
- 最初对树树皮的隔离导致了供应的限制,推动了对替代生产方法的研究.
- 合成,半合成和生物技术的进步对于满足需求至关重要.
研究的目的:
- 审查和突出Taxol (帕克利塔克塞尔) 获取和提高生物可用性的新策略.
- 讨论将尖端技术集成到Taxol生产和治疗应用中.
- 探索Taxol研究和开发的未来方向.
主要方法:
- 从自然资源中提取 (历史背景).
- 化学合成和半合成.
- 生物技术方法包括细胞悬浮培养和生物转化.
- 纳米技术用于药物输送和向.
- 人工智能 (AI) 在过程开发中的应用.
主要成果:
- 生物技术方法为Taxol生产提供了高产量和产品质量.
- 纳米技术提高了药物保留时间和瘤度,减少了全身副作用.
- 人工智能为优化TAXOL获取和生物可用性提供了新的途径.
结论:
- 基于生物技术和纳米技术的创新方法正在彻底改变Taxol的生产和治疗疗效.
- 像人工智能这样的先进技术的协同作用有望在癌症治疗策略中取得重大进展.
- 持续的研究对于最大限度地发挥Taxol在瘤学中的潜力至关重要.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


